Empresa Maravai LifeSciences Holdings, Inc.
Acciones
MRVI
US56600D1072
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
7,85 USD | +1,95 % | +6,51 % | +19,85 % |
Resumen de negocios
Número de empleados: 650
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Nucleic Acid Production
77,8
%
| 813 | 92,1 % | 225 | 77,8 % | -72,36 % |
Biologics Safety Testing
22,2
%
| 70 | 7,9 % | 64 | 22,2 % | -8,23 % |
Eliminations
0,0
%
| 0 | 0,0 % | 0 | 0,0 % | -57,14 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
North America
48,8
%
| 339 | 38,4 % | 141 | 48,8 % | -58,45 % |
Asia Pacific
33,7
%
| 110 | 12,4 % | 97 | 33,7 % | -11,25 % |
EMEA
17,3
%
| 433 | 49,0 % | 50 | 17,3 % | -88,47 % |
Latin and Central America
0,2
%
| 1 | 0,1 % | 1 | 0,2 % | -34,78 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
William Martin
CEO | Chief Executive Officer | 49 | 30/09/22 |
Carl Hull
FOU | Founder | 66 | 01/03/14 |
Kevin Herde
DFI | Director of Finance/CFO | 53 | 01/05/17 |
Mike Houston
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kate Broderick
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/22 |
Peter Leddy
ADM | Chief Administrative Officer | 59 | 27/06/22 |
Deb Hart
IRC | Investor Relations Contact | - | - |
Christine Dolan
PRN | Corporate Officer/Principal | 56 | 10/10/17 |
Kurt Oreshack
LAW | General Counsel | 44 | 01/11/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Dean Mihas
BRD | Director/Board Member | 57 | 01/03/16 |
Sean Cunningham
BRD | Director/Board Member | 48 | 01/03/16 |
Gregory Lucier
BRD | Director/Board Member | 60 | 01/01/20 |
Susannah Gray
BRD | Director/Board Member | 63 | 01/11/20 |
Carl Hull
FOU | Founder | 66 | 01/03/14 |
John DeFord
BRD | Director/Board Member | 62 | 20/07/23 |
Director/Board Member | 46 | 01/03/16 | |
Murali Prahalad
BRD | Director/Board Member | 52 | 01/08/16 |
Jessica Hopfield
BRD | Director/Board Member | 59 | 19/11/20 |
Anat Ashkenazi
BRD | Director/Board Member | 51 | 19/11/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 119 094 026 | 0 | 0 | 42,84 % |
Acción B | 1 | 132 654 801 | 107 851 041 ( 81,30 %) | 0 |
Información de la empresa
Maravai Lifesciences Holdings, Inc.
10770 Wateridge Circle Suite 200
92121, San Diego
+
http://www.maravai.comSector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+19,85 % | 1041,34 M | |
-20,55 % | 10,81 mil M | |
+47,97 % | 3360,06 M | |
-32,75 % | 2217,09 M | |
-14,15 % | 2159,85 M | |
-26,06 % | 1554,94 M | |
-2,62 % | 746 M | |
-31,67 % | 425 M | |
-43,88 % | 405 M | |
+29,03 % | 378 M |
- Bolsa de valores
- Acciones
- Acción MRVI
- Empresa Maravai LifeSciences Holdings, Inc.